| 1 |
32219694 | In vitro inhibition of human cytochrome P450 enzymes by the novel atypical antipsychotic drug asenapine: a prediction of possible drug-drug interactions. | 2020 Jun |
1 |
| 2 |
32279279 | The atypical neuroleptics iloperidone and lurasidone inhibit human cytochrome P450 enzymes in vitro. Evaluation of potential metabolic interactions. | 2020 Dec |
1 |
| 3 |
32941854 | Asenapine and iloperidone decrease the expression of major cytochrome P450 enzymes CYP1A2 and CYP3A4 in human hepatocytes. A significance for drug-drug interactions during combined therapy. | 2020 Nov 1 |
1 |
| 4 |
26481538 | Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study. | 2015 Dec |
1 |
| 5 |
15056479 | The metabolism of the piperazine-type phenothiazine neuroleptic perazine by the human cytochrome P-450 isoenzymes. | 2004 May |
2 |
| 6 |
14581727 | Effects of cytochrome P-450 inducers on the perazine metabolism in a primary culture of human hepatocytes. | 2003 Jul-Aug |
1 |
| 7 |
11026737 | Cytochrome P-450 enzymes and FMO3 contribute to the disposition of the antipsychotic drug perazine in vitro. | 2000 Sep |
1 |